Aia-Pack Ca 19-9
K023239 is the FDA 510(k) clearance record for AIA-PACK CA 19-9, a class II device, cleared for Tosoh Corp. on under FDA product code NIG (System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer). FDA's definition for product code NIG reads: "An in vitro diagnostic test for the quantitative measurement of the CA 19-9 tumor associated antigen in human serum or plasma. The test is intended as an aid in the management of patients with confirmed pancreatic cancer and serial...". FDA records list 2 510(k) clearances for Tosoh Corp. As of , FDA records show no recalls naming K023239.
Clearance record
- Decision date
- Received
- (87 days to decision)
- Product code
- NIG System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer
- Regulation
- 21 CFR 866.6010
- Device class
- Class II
- Review panel
- Immunology
- Applicant
- Tosoh Corp. 73 Cogwheel Ln., Seymour CT
- 510(k) summary
- Statement
- Third party review
- No
Clearances, product code NIG
Trailing 12 monthsShow the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 1 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
